About this trial
The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique. Predictive factors of poor prognosis will also be analyzed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult (≥18 years) patients,
Admitted to University Hospital of Martinique with subarachnoid hemorrhage of aneurysmal origin between 01/01/2013 and 31/12/2021,
Informed patient/next-of-kin/treating physician consent for research participation.
Disqualifiers
Other causes of subarachnoid hemorrhage of non-aneurysmal origin (traumatic, arteriovenous malformation, cerebral tumor, cerebral thrombophlebitis).
Trial population
Patients hospitalized in Martinique for subarachnoid hemorrhage of aneurysmal origin
Trial design
Cohort
Retrospective
Treatments tested in this trial
Usual patient care for patients hospitalized for subarachnoid hemorrhage of aneurysmal origin
Other interventionDuring hospitalization (2013-2021), patients were managed after multidisciplinary consultation in accordance with national recommendations between resuscitators, neurosurgeons and neuroradiologists, depending on the severity of the initial management and the patient's comorbidities, either by interventional radiology, neurosurgery or medical treatment.
Treatment groups
Trial outcomes
Primary outcomes
Evaluate mortality in patients hospitalized for subarachnoid hemorrhage of aneurysmal origin over a 9-year period (2013-2021) in Martinique.
Mortality of subarachnoid hemorrhage of aneurysmal origin.
Secondary outcomes
Evaluate the clinical outcome of these patients.
Patient's clinical outcome (mortality, impairment of patient autonomy, impairment of patient's level of dependece), assessed with the modified Rankin score at discharge and at a distance from hospitalization (minimum delay: 2.5 years).
Analyze the factors associated with a significant impairment of autonomy and/or dependence.
Predictive factors associated with significant impairment of patient autonomy and/or dependence (modified Rankin score = 4 or 5): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size
Analyze the factors associated with death.
Predictive factors associated with death (modified Rankin score = 6): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size.
Analyze the factors associated with a poor prognosis (death AND/OR significant impairment of autonomy/dependence).
Predictive factors associated with a poor prognosis (modified Rankin score ≥ 4: death AND/OR impaired patient autonomy and/or dependence): age, degree of consciousness at the time of treatment (WFNS score), amount of blood in the meningeal spaces (Fisher score), aneurysm size.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.